ID

37147

Descrizione

Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan; ODM derived from: https://clinicaltrials.gov/show/NCT02335606

collegamento

https://clinicaltrials.gov/show/NCT02335606

Keywords

versioni (1)
  1. 04/07/19 04/07/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

4 luglio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Rheumatoid Arthritis NCT02335606

Inglese

Eligibility Rheumatoid Arthritis NCT02335606

1 moduli  
Criteria
Descrizione

Criteria

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
≥ 20 years of age
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
who give informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
confirmed diagnosis of ra (as defined by american college of rheumatology revised 1987 criteria) and has ≥ 4 of the criteria listed below for ≥6 weeks before study enrollment
Descrizione

Rheumatoid Arthritis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003873
who self-pay or who are reimbursed by bnhi for abatacept treatment
Descrizione

Self-pay | Reimbursement National Health Insurance | abatacept

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3530213
UMLS CUI [2,1]
C0021684
UMLS CUI [2,2]
C0027452
UMLS CUI [3]
C1619966
with latent tb or who are receiving anti-tb treatment (inh 300 mg, qd) 1 month prior to using abatacept and continuously up to a total of 9 months willing to follow taiwan risk management plan guidelines as required by taiwan health authorities
Descrizione

Latent Tuberculosis | Antitubercular Agents U/day | Adherence Risk Management Plan

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1609538
UMLS CUI [2,1]
C0003448
UMLS CUI [2,2]
C0456683
UMLS CUI [3,1]
C1510802
UMLS CUI [3,2]
C2699091
are being treated with abatacept or are abatacept treatment naïve and are initiating abatacept therapy
Descrizione

Abatacept | Abatacept Absent | Abatacept Initiation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1619966
UMLS CUI [2,1]
C1619966
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1619966
UMLS CUI [3,2]
C1704686
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast feeding
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
with active tb
Descrizione

Tuberculosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0041296
hbsag (+)and/or anti-hcv(+) and/or hbv dna(+)
Descrizione

Hepatitis B surface antigen positive | Hepatitis C Antibodies Positive | Hepatitis B DNA assay positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2,1]
C0166049
UMLS CUI [2,2]
C1514241
UMLS CUI [3]
C1168040
have cancer (patients who were treated and have no sign of cancer for > 10 years can be included)
Descrizione

Malignant Neoplasms | Exception Malignant Neoplasm Treated | Exception Neoplasm Free of Duration

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0006826
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0006826
UMLS CUI [3,3]
C0332296
UMLS CUI [3,4]
C0449238
are allergic to abatacept
Descrizione

Hypersensitivity Abatacept

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1619966
enrolled in other ra clinical studies
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
Ritorna all'inizio della pagina

Similar models

Eligibility Rheumatoid Arthritis NCT02335606

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Age
Item
≥ 20 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
who give informed consent
boolean
C0021430 (UMLS CUI [1])
Rheumatoid Arthritis
Item
confirmed diagnosis of ra (as defined by american college of rheumatology revised 1987 criteria) and has ≥ 4 of the criteria listed below for ≥6 weeks before study enrollment
boolean
C0003873 (UMLS CUI [1])
Self-pay | Reimbursement National Health Insurance | abatacept
Item
who self-pay or who are reimbursed by bnhi for abatacept treatment
boolean
C3530213 (UMLS CUI [1])
C0021684 (UMLS CUI [2,1])
C0027452 (UMLS CUI [2,2])
C1619966 (UMLS CUI [3])
Latent Tuberculosis | Antitubercular Agents U/day | Adherence Risk Management Plan
Item
with latent tb or who are receiving anti-tb treatment (inh 300 mg, qd) 1 month prior to using abatacept and continuously up to a total of 9 months willing to follow taiwan risk management plan guidelines as required by taiwan health authorities
boolean
C1609538 (UMLS CUI [1])
C0003448 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C1510802 (UMLS CUI [3,1])
C2699091 (UMLS CUI [3,2])
Abatacept | Abatacept Absent | Abatacept Initiation
Item
are being treated with abatacept or are abatacept treatment naïve and are initiating abatacept therapy
boolean
C1619966 (UMLS CUI [1])
C1619966 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1619966 (UMLS CUI [3,1])
C1704686 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Tuberculosis
Item
with active tb
boolean
C0041296 (UMLS CUI [1])
Hepatitis B surface antigen positive | Hepatitis C Antibodies Positive | Hepatitis B DNA assay positive
Item
hbsag (+)and/or anti-hcv(+) and/or hbv dna(+)
boolean
C0149709 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1168040 (UMLS CUI [3])
Malignant Neoplasms | Exception Malignant Neoplasm Treated | Exception Neoplasm Free of Duration
Item
have cancer (patients who were treated and have no sign of cancer for > 10 years can be included)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
C0449238 (UMLS CUI [3,4])
Hypersensitivity Abatacept
Item
are allergic to abatacept
boolean
C0020517 (UMLS CUI [1,1])
C1619966 (UMLS CUI [1,2])
Study Subject Participation Status
Item
enrolled in other ra clinical studies
boolean
C2348568 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial